C oronary artery calcium (CAC) scanning for risk assessment in the asymptomatic population has been the subject of more than 2,500 papers in the peer-reviewed literature. Yet its role remains controversial, incorporation into guidelines has been variable, and insurance coverage is virtually nonexistent, with at least 1 major carrier labeling it investigational (2) . Despite the overwhelming peer-reviewed data supporting the role of CAC in the primary prevention of coronary heart disease (CHD), its penetration into clinical practice has been inexplicably low. Screening for lung, breast, and colon cancer has been officially endorsed by the U.S. Preventive Services Task Force, the agency on which coverage decisions are largely based. On the other hand, coronary artery disease (CAD), which is responsible for more deaths than all cancers combined, has been considered to lack sufficient evidence to be considered for screening. Instead, reliance is placed on risk assessment by various risk factorbased paradigms. This paper summarizes the data supporting the application of CAC to the care of the individual patient, discusses the ongoing controversy, and outlines directions for future research.
THE CAC SCAN
The CAC scan is a noncontrast, limited chest computed tomography (CT) scan acquired with an w3 RADIATION. The radiation exposure should not exceed 1.0 mSv (6) and has progressively decreased to #1 mSv, comparable to mammography (0.8 mSv).
Newer algorithms using iterative reconstruction have decreased the mean dose to 0.37 mSv (7), but are variable from vendor to vendor. Further reductions are to be expected with the implementation of modelbased iterative reconstruction, with higher signal-tonoise ratios facilitating lower current, but validation will be required. Several studies have projected a small but finite increase in lifetime attributable cancer risk to CAC scanning, but it is important to note that this is a predicted rather than observed risk (8) .
EPIDEMIOLOGY. By comparing a subject's calcium score with that of others of the same age, sex, and ethnicity through the use of large databases of asymptomatic subjects, a calcium percentile is generated (9); higher than the 75th percentile is considered high risk, irrespective of the score, and indicates premature atherosclerosis. Variations according to sex and ethnicity have been described. In the Multi-Ethnic Study of Atherosclerosis (MESA) of 6,110 asymptomatic patients, men had higher calcium levels than women, and the amount and prevalence of calcium continually increased with increasing age (10) . In men, Caucasians and Hispanics had the first and second highest scores, respectively; blacks had the lowest scores at the younger ages, and Chinese had the lowest scores at the older ages. In women, Perhaps the most important study is the MESA, a National Heart, Lung, and Blood Institute-sponsored prospective population cohort registry evaluation of 6,814 individuals followed for 3.8 years (11) in the initial report and as long as 14.5 years in subgroups.
Compared with patients with a CAC score of 0, the hazard ratios (HRs) for a coronary event were 7.73 for those with a CAC score of 101 to 300, and 9.67 for a the adjusted HR for a CAC score >400 was 5.36 (14) .
After a median 7.6-year follow-up in the 1,330 Amalgamation of the data from 5 large prospective, randomized studies, 3 with events defined as CHD death, myocardial infarction, and revascularization (11, 22, 23) and 2 with CHD death and myocardial infarction (21,24) yields annual event rates that can be translated into 10-year FRS equivalents ( Table 2) .
A CAC score >400 is a CHD equivalent, with 10-year event rates exceeding 20% in asymptomatic patients. population-based studies is shown in Table 3 (20,30,31 
Coronary Artery Calcium CT angiography has replaced CAC for this indication.
In 1,897 asymptomatic patients followed for 6.8 years in the Rotterdam study, the HRs for the development of congestive heart failure increased with increasing CAC score to a peak of 4.1 in the CAC score >400 group, with an NRI of 34% for the prediction of congestive heart failure compared with standard congestive heart failure predictors (35) . CAC prognostic data have challenged the ingrained concept of diabetes mellitus as a CHD equivalent.
Patients with diabetes and a CAC score >0 have higher risks than those without diabetes and similar CAC score, but the absence of CAC conveys a similar low risk in both groups ( Table 4 ) (12). Therefore, the more appropriate rationale is for a straightforward (Left) Coronary artery calcium (CAC) was present in 95% of patients 57 AE 11 years of age presenting with first myocardial infarction (MI) or unstable angina (UA) (31) . (Right) CAC was present in 95% of patients age 41 AE 7 years of age presenting with first MI (32).
ASHD ¼ atherosclerotic heart disease; pts ¼ patients. Reprinted with permission from
Hecht and Narula (12) . Risk Development in Young Adults) study, the incidence of a CAC score >0 was 9.9% and the incidence of CAC score >100 was 1.8% (44) . The percentages increased with increasing FRS, with a CAC score >100 incidence of 17.2% in those with an FRS >10% in whom the number needed to scan to uncover a CAC score >100 was only 6 patients.
Although CAC scanning is not guideline recommended in this age group, it can be helpful in statin use decision making in these younger high-FRS individuals.
POST-CAC SCANNING TESTING
The appropriateness of stress testing after CAC scanning in asymptomatic patients is directly related to the CAC score. The incidence of abnormal nuclear stress testing is 1.3%, 11.3%, and 35.2% for CAC scores <100, 100 to 400, and >400, respectively (45) (Figure 4) . It is only in the >400 group that the pretest likelihood is sufficiently high to warrant further evaluation with myocardial perfusion imaging, for which there is a IIb recommendation (38 in those with CAC scores of 1 to 99, and 44% in those with a CAC score of 0 (p < 0.0001) (47) . Similarly, in 980 asymptomatic subjects followed for 3 years, aspirin therapy initiation, dietary changes, and exercise increased significantly from those with a CAC score of 0 (29%, 33%, and 44%, respectively) and was highest with CAC scores >400 (61%, 67%, and 56%, respectively) (48) . Finally, after a 6-year follow-up of 1,640 asymptomatic subjects, the odds ratios for those with a CAC score >0 compared with a CAC score of 0 for use of statins, aspirin, and a statin þ aspirin were It is only in the CACS >400 group that the pre-test probability is sufficiently high to warrant stress testing. CAC ¼ coronary artery calcium; CACS ¼ coronary artery calcium score; SPECT ¼ single-photon emission computed tomography. Reprinted with permission from Hacker and Becker (45) . the moderate-to high-intensity statin group to be 68 for a CAC score of 0, 42 for a CAC score of 1 to 100, and 24 for a CAC score >100. In the moderate-intensity statin group, the NNTs for the same CAC groups were 246, 47, and 39, respectively (55).
Thus, in both the older and younger populations, CAC efficiently uncovers higher risk patients who most need to be treated and identifies those who will most benefit from therapy irrespective of lipid or CRP abnormalities. Coronary Artery Calcium the atherosclerotic process. CAC progression >15%/ year was associated with a HR of 2.98 (p < 0.0001) for all-cause mortality in 4,609 primary prevention patients followed for 3.1 years (60).
COST-EFFECTIVENESS
In 6,778 MESA subjects followed for 7.6 years for all CHD events, patients with 0 baseline scores and increases in CAC score >5 Agatston units (AU) per year had a 1.4 HR (61). In those with >0 baseline Conversion from a CAC score of 0 to a CAC score >0 occurred in 2 (0.5%), 5 (1.2%), 24 (5.7%), 26 (6.2%), Reprinted with permission from Hecht and Narula (12) . TC ¼ total cholesterol; TG ¼ triglycerides; other abbreviations as in Figures 2 and 5 .
Coronary Artery Calcium and 49 (11.6%) in years 1, 2, 3, 4, and 5, respectively.
Time to conversion was not related to any risk factor, and the CAC Agatston score on conversion was 19 AE 19.
There are no data regarding the optimal time for repeat scanning in patients with a CAC score >0.
Rather, logic dictates that the greater the concern, the shorter should be the interval. The low radiation dose makes repeat scanning less problematic.
CAC AND CLINICAL PRACTICE GUIDELINES
OLDER GUIDELINES. The Screening for Heart Attack Prevention and Education (SHAPE) recommendation was the first CAC-based paradigm and was met with great controversy (65) (Figure 7) . CAC assessment was Consequently, the 2010 guideline, rather than the 2013 guidelines, should be used for patients at intermediate risk (10% to 20% FRS) to determine the need for statin treatment (71) . With an NRI of w33%, use for high-risk patients may be reasonable as well ( Table 3) .
The MESA NRI of 54.4% for the 6% to 20% FRS group included low-to intermediate-risk patients (6% to 10%), but specific numbers for this group were not presented. However, as previously noted, the number needed to scan to uncover a high-risk patient with a CAC score >300 in the 7.5% to 10.0% FRS group in the MESA was only 7 (52), which may make it reasonable to use for these patients as well, although further confirmation is needed.
As discussed in the following, the absence of ran- by the 2014 Center for Medicare and Medicaid Services decision to provide coverage for lung scans in a defined high-risk population (84). There will be an estimated 6.6 million lung scan-eligible patients, almost all of whom will be at intermediate or high risk of CAD, who will have scans analyzable for CAC (85) ( Figure 9 ). Lung CT scanning is routinely performed without electrocardiography gating, whereas CAC scanning uses gating to minimize motion artifact.
Although CAC is apparent on nongated chest CT screening and several analytic approaches have been used to obtain Agatston scores, they are less than ideal. Fortunately, electrocardiography gating can be implemented without an increase in radiation, and CAC scoring on all chest CT scans has been recommended (86).
ENVIRONMENTAL. Second-hand tobacco smoke (87) and traffic associated particulate matter exposure (88) have been associated with increased CAD risk and increased CAC. The ability to identify patients adversely affected by other environmental and workrelated pollutants will be an area of interest. 
